Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety and Efficacy of Sofosbuvir + Velpatasvir With or Without Ribavirin in Treatment-Naive Adults With Chronic HCV Infection

ClinicalTrials.gov ID: NCT01858766

Public ClinicalTrials.gov record NCT01858766. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 8:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir + GS-5816 for 12 Weeks in Treatment-Naive Subjects With Chronic HCV Infection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objectives of this study are to evaluate the antiviral efficacy, safety, and tolerability of sofosbuvir (SOF) + velpatasvir (VEL; GS-5816) with or without ribavirin (RBV) in treatment-naive adults with chronic genotype (GT) 1, 2, 3, 4, 5, or 6 hepatitis C virus (HCV) infection.

Study identification

NCT ID
NCT01858766
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gilead Sciences
Industry
Enrollment
379 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2013 (Type not available)
Primary completion
May 2014 (Actual)
Completion
Aug 2014 (Actual)
Last update posted
Nov 14, 2018

2013 – 2014

United States locations

U.S. sites
50
U.S. states
19
U.S. cities
41
Facility City State ZIP Site status
UCSD La Jolla California 92037 —
University of California San Diego Medical Center La Jolla California 92093 —
VA Long Beach Healthcare System Long Beach California 90822 —
Los Angeles Medical Center Los Angeles California 90027 —
Ruane Peter J MD Incorporated Los Angeles California 90036 —
Cedars Sinai Medical Center Los Angeles California 90048 —
National Research Institute Los Angeles California 90057 —
Huntington Medical Research Institutes Liver Center Pasadena California 91105 —
Kaiser Permanente Medical Grp San Diego California 92120 —
Medical Associates Research Group, Inc. San Diego California 92123 —
Kaiser Permante San Francisco California 94080 —
University of Colorado Denver Colorado 80220 —
University of Florida Center for Clinical Trials Research Gainesville Florida 32610 —
Borland-Groover Clinic Jacksonville Florida 32216 —
University of Miami Miami Florida 33136 —
Orlando Immunology Center Orlando Florida 32803 —
Tampa General Hospital Tampa Florida 33606 —
South Florida Center of Gastroenterology, P.A Wellington Florida 33414 —
Center For Hepatitis C/Atlanta Medical Center Atlanta Georgia 30344 —
Gastrointestinal Specialists of Georgia, PC Marietta Georgia 30060 —
Northwestern University Chicago Illinois 60611 —
Indiana University School of Medicine Indianapolis Indiana 46202 —
Indianapolis Gastroenterology & Hepatology, Inc.- ARC Indianapolis Indiana 46237 —
Mercy Medical Ctr Baltimore Maryland 21202 —
Johns Hopkins University Baltimore Maryland 21287 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
Henry Ford Health System Detroit Michigan 48202 —
ID Care Hillsborough New Jersey 08844 —
Southwest C.A.R.E. Center Santa Fe New Mexico 87505 —
North Shore/Long Island Jewish PRIME Lake Success New York 11041 —
Weill Cornell Medical College-New York Presbyterian Hospital New York New York 10021 —
Asheville Gastroenterology Associates, P.A. Asheville North Carolina 28801 —
Duke University Medical Center Durham North Carolina 27710 —
Cumberland Research Associates, LLC Fayetteville North Carolina 28303 —
Digestive Health Specialists, PA Winston-Salem North Carolina 27103 —
University of Pennsylvania Health System Philadelphia Pennsylvania 19104 —
UPMC Center For Liver Diseases Pittsburgh Pennsylvania 15213 —
VA Pittsburgh Healthcare System Pittsburgh Pennsylvania 15240 —
University Gastroenterology Providence Rhode Island 02905 —
Gastro One Germantown Tennessee 38138 —
Nashville Gastrointestinal Specialists Inc. Nashville Tennessee 37211 —
Texas Clinical Research Institute, LLC Arlington Texas 76012 —
Methodist Transplant Physicians Dallas Texas 75203 —
Alamo Medical Research, LTD d/b/a American Research Corporation San Antonio Texas 78215 —
Metropolitan Research Fairfax Virginia 22031 —
INOVA Institute of Research & Education Falls Church Virginia 22042 —
The Liver Institute of Virginia Newport News Virginia 23602 —
Digestive and Liver Disease Specialists, Ltd. Norfolk Virginia 23502 —
Virginia Mason Medical Center Seattle Washington 98101 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01858766, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 14, 2018 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01858766 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →